Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Australia Trials ‘More Transparent’ PBS Listing Procedure

The Move Involves Changes To Public Summary Document Process

Executive Summary

Stakeholders have been asked to test-run a new approach to preparing Public Summary Documents for medicines submitted for reimbursement in Australia.

You may also be interested in...



Australia To Streamline Drug Reimbursement Listing Processes From July

Pharmaceutical companies in Australia can look forward to more streamlined processes for the submission and evaluation of new drugs for listing on the Pharmaceutical Benefits Scheme from July. 

UK To Seek Only Limited Regulatory Alignment With EU

Despite the life sciences industry’s call for continued alignment of medicines regulation with the EU from next year and for some sort of co-operation with the European Medicines Agency, it seems the UK government is prepared to make only small concessions.

‘No Unified Patent Court For Us’, Says UK Government

The UK’s decision to pull out of Europe’s Unified Patent Court system throws the future of the whole project into doubt.

Topics

UsernamePublicRestriction

Register

PS141150

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel